Postmarketing Safety Data Drives Significant Value Even in the Absence of Identified Signals – Part 1 of 3

By |2019-05-03T13:54:56+00:00July 2nd, 2015|

Postmarketing Safety Data Drives Significant Value Even in the Absence of Identified Signals - Part 1 of 3 This is the first of a three part series on the value of disclosure of postmarketing safety information by pharmaceutical manufacturers. Spontaneous postmarketing safety data is typically kept confidential (there is no requirement for manufacturers to [...]